- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Significant Ownership of Bihua Chen
- Signature - Title
- /s/ Bihua Chen - Chen Bihua
- Location
- Boston, MA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Bihua Chen.
Follow Filing Activity
Follow Bihua Chen and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Bihua Chen
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HLXB | Helix Acquisition Corp. II | Class A ordinary shares, $0.0001 par value per share | 32% | $81,352,890 | 7,389,000 | Bihua Chen | 28 Feb 2025 | ||
| HLXB | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 23% | 17,878,594 | Bihua Chen | 11 Aug 2025 | |||
| MLTX | MoonLake Immunotherapeutics | Class A Ordinary Shares | 3.1% | $108,084,177 | 1,994,173 | Chen Bihua | 30 Sep 2025 | ||
| BMEA | Biomea Fusion, Inc. | Common Stock | 1.5% | $2,143,436 | -$5,295,734 | 1,060,792 | -71% | Chen Bihua | 22 Oct 2025 |
Schedules 13D/G Reported by Bihua Chen:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.